Corcept Therapeutics | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
Acadia Pharmaceuticals USD 40.21M 12.43M 2025-06
Alaunos Therapeutics USD -7843000 633K 2023-12
ANI Pharmaceuticals USD 10.52M 9.47M 2025-06
Ardelyx USD 4.68M 5.45M 2024-12
Aurora Cannabis CAD 32.07M 31.47M 2024-12
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Canopy Growth CAD -121580000 9.67M 2024-12
Corcept Therapeutics USD 31.69M 22.07M 2025-06
Eli Lilly USD 6.78B 3.32B 2025-06
J&J USD 13.63B 8.21B 2025-03
Knight Therapeutics CAD -7144000 19.01M 2024-03
Merck USD 6.77B 864M 2025-06
Novartis USD 4.53B 124M 2025-06
Novartis USD 4.66B 269M 2024-12
Pacira USD -1927000 10.63M 2025-06
Pfizer USD 3.04B 259M 2025-06
Supernus Pharmaceuticals USD 16.67M 22.5M 2025-06
TG Therapeutics USD 30.92M 25.45M 2025-06


Corcept Therapeutics Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.